Imaging in COVID-19: A Review

Abstract

The coronavirus disease 2019 (COVID-19) outbreak, which started in Wuhan, China, has rapidly spread worldwide. It is a
highly infectious viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and diagnosed by
real-time reverse transcription-polymerase chain reaction (RT-PCR) of the viral nucleic acid. COVID-19 usually presents with
symptoms related to respiratory system; however, lately there have been number of reports with extrapulmonary manifestations.
Some patients have shown severe cardiovascular damage, acute-onset hepatitis, acute renal failure, encephalitis and myositis.
Although the role of imaging has been limited in diagnosis, it is becoming more and more central to supplementing diagnosis,
assessing severity, progression and in the follow-up of these patients. This article is aimed to review the role of imaging in
COVID-19.